Cargando…

Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B

Patients prescribed liposomal-amphotericin B (L-AMB) frequently require supplemental potassium to prevent hypokalemia. The aim of this retrospective study was to examine the appropriate potassium supplementation conditions to treat hypokalemia induced by L-AMB. The subjects were 100 hematological pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	USAMI, EISEKI, KIMURA, MICHIO, KANEMATSU, TETSUFUMI, YOSHIDA, SHINYA, MORI, TAKAYUKI, NAKASHIMA, KEIJI, MATSUOKA, TOMOKO, YOSHIMURA, TOMOAKI, MORI, HIROMI, SUGIYAMA, TADASHI, TERAMACHI, HITOMI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965133/ https://www.ncbi.nlm.nih.gov/pubmed/24669255 http://dx.doi.org/10.3892/etm.2014.1534

Ejemplares similares

Oral anticancer agent medication adherence by outpatients
por: KIMURA, MICHIO, et al.
Publicado: (2014)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
por: Asano, Hiroki, et al.
Publicado: (2023)

Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study
por: Ota, Yuki, et al.
Publicado: (2021)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Severe Hypokalemia Precipitated Under Anesthesia Due to Conventional Amphotericin B in a Patient with Invasive Aspergillosis
por: Parida, Satyen, et al.
Publicado: (2021)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Severe Hypokalemia and Metabolic Alkalosis Caused by Licorice Discovered During the Treatment of Intraoperative Hypoxemia
por: Shibata, Taisuke, et al.
Publicado: (2022)

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
por: Krogager, Maria Lukács, et al.
Publicado: (2020)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

Comparative study on 3 oral potassium formulations for treatment of hypokalemia in dairy cows
por: Wittek, Thomas, et al.
Publicado: (2019)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine
por: Zhang, Xiangcai, et al.
Publicado: (2016)

Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
por: Teixeira-Santos, Rita, et al.
Publicado: (2016)

Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole
por: McMullan, Brendan, et al.
Publicado: (2016)

Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
por: Personett, Heather A., et al.
Publicado: (2019)

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
por: Groll, Andreas H, et al.
Publicado: (2019)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Amphotericin-B liposomal: Acute kidney injury: case report
Publicado: (2020)

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
por: Wasmann, Roeland E, et al.
Publicado: (2020)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Amphotericin-B-liposomal/posaconazole: Mixed transaminitis: case report
Publicado: (2021)

Amphotericin-b-liposomal/azithromycin/hydroxychloroquine: No response: case report
Publicado: (2021)

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

Amphotericin-b-liposomal/isavuconazole: Lack of efficacy: case report
Publicado: (2021)

Amphotericin B liposomal/posaconazole: Lack of efficacy: case report
Publicado: (2022)

Amphotericin-B-liposomal/insulin: Lack of efficacy: case report
Publicado: (2022)

Hypokalemia in Patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma
por: Takeda, Takayuki, et al.
Publicado: (2014)

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
por: Toprak, Demet, et al.
Publicado: (2015)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis
por: Nattusamy, Loganathan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lbil6tk30gp8tqfb8p0rdk783t